Literature DB >> 10204118

The cadherin-catenin system: implications for growth and differentiation of endocrine tissues.

E Pötter1, C Bergwitz, G Brabant.   

Abstract

Cell-cell adhesion, as mediated by the cadherin-catenin system, is a prerequisite for normal cell function and the preservation of tissue integrity. With recent progress in our understanding, beta-catenin as a component of a complex signal transduction pathway may serve as a common switch in central processes that regulate cellular differentiation and growth. The function of the cadherin-catenin system in cell adhesion as well as in intracellular signaling, appears to be subjected to multifactorial control by a variety of different mechanisms, and data on a hormonal control of these signaling pathways, even though scarce to date, suggest an important regulatory influence in many cellular systems. Loss of E-cadherin-catenin function was described in many tumors along with an increased invasiveness and a decreased prognosis of many carcinomas, including tumors of endocrine glands and their target systems, and a causal role of this loss-of-function in the multifactorial process of tumorigenesis was recently proven in genetic mouse models. Modification of E-caderin-catenin function in endocrine and nonendocrine tumors may involve germline and somatic gene mutations, epigenetic mechanisms such as gene silencing due to promotor-hypermethylation, and posttranscriptional events, likely to be involved in many endocrine tissues and their target organs. Such events may converge on nuclear activation of oncogenes such as c-myc by the beta-catenin/TCF4 complex. The expression and functional status of the components of the cadherin-catenin system may serve as prognostic markers for endocrine and nonendocrine tumors. The frequent involvement of functional dysregulation in many tumors raises hopes that better definition of the regulation of all components of the cadherin-catenin system and their response to extracellular modulators may eventually lead to new therapeutic approaches for these tumors and help to prevent, more specifically, growth, invasion, and metastasis of these carcinomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10204118     DOI: 10.1210/edrv.20.2.0362

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  31 in total

1.  Effect of disrupting cell contact on the nuclear accumulation of beta-catenin and subsequent apoptosis of rat ovarian surface epithelial cells in vitro.

Authors:  J J Peluso; A Pappalardo; S A Hess
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.633

2.  Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma.

Authors:  M J Pukkila; J A Virtaniemi; E J Kumpulainen; R T Pirinen; R T Johansson; H J Valtonen; M T Juhola; V M Kosma
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

3.  Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.

Authors:  R T Pirinen; P Hirvikoski; R T Johansson; S Hollmén; V M Kosma
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

4.  Effect of E-cadherin expression on hormone production in rat anterior pituitary lactotrophs in vitro.

Authors:  Kenji Kusumoto; Motoshi Kikuchi; Ken Fujiwara; Kotaro Horiguchi; Tom Kouki; Kotaro Kawanishi; Takashi Yashiro
Journal:  Acta Histochem Cytochem       Date:  2010-04-21       Impact factor: 1.938

5.  Reciprocal regulation by estradiol 17-beta of ezrin and cadherin-catenin complexes in pituitary GH3 cells.

Authors:  Perry M Smith; C Amanda Heinrich; Stacey Pappas; John J Peluso; Ann Cowan; Bruce A White
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

6.  Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.

Authors:  Beatrice Rubin; Daniela Regazzo; Marco Redaelli; Carla Mucignat; Marilisa Citton; Maurizio Iacobone; Carla Scaroni; Corrado Betterle; Franco Mantero; Ambrogio Fassina; Raffaele Pezzani; Marco Boscaro
Journal:  Tumour Biol       Date:  2016-07-28

Review 7.  CDH1 germline mutation in hereditary gastric carcinoma.

Authors:  Hai-Dan Wang; Jun Ren; Lian Zhang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

8.  Cell surface and secreted protein profiles of human thyroid cancer cell lines reveal distinct glycoprotein patterns.

Authors:  Arthur Arcinas; Ten-Yang Yen; Electron Kebebew; Bruce A Macher
Journal:  J Proteome Res       Date:  2009-08       Impact factor: 4.466

9.  PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance.

Authors:  Rohit N Kulkarni; Ulupi S Jhala; Jonathon N Winnay; Stan Krajewski; Marc Montminy; C Ronald Kahn
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

10.  RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation.

Authors:  Giuliana Cassinelli; Enrica Favini; Debora Degl'Innocenti; Alessandro Salvi; Giuseppina De Petro; Marco A Pierotti; Franco Zunino; Maria Grazia Borrello; Cinzia Lanzi
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.